Muolokwu CE, Chaulagain B, Gothwal A et al (2024) Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimers disease
Methylene Blue
In animal models, intranasal administration of GHK-Cu improved cognitive functions, reduced amyloid plaques, and decreased inflammation in the brain, suggesting its potential as a therapeutic agent for Alzheimers disease and age-related cognitive decline 10
When I asked Michael if he felt uncomfortable putting untested products into his body, he, too, invoked COVID shots, calling them a vaccine that also had no long-term studies. So its, like, Pick your poison, he said
The comparison is therefore partly apples-to-oranges: retatrutide is a finished multi-mechanism molecule, whereas cagrilintides headline performance depends on the partner it is combined with